MSCs conditioned media and umbilical cord blood plasma metabolomics and composition

PLoS One. 2014 Nov 25;9(11):e113769. doi: 10.1371/journal.pone.0113769. eCollection 2014.

Abstract

Human mesenchymal stem cells (hMSCs) from umbilical cord (UC) blood (UCB) and matrix are tested clinically for a variety of pathologies but in vitro expansion using culture media containing fetal bovine serum (FBS) is essential to achieve appropriate cell numbers for clinical use. Human UCB plasma (hUCBP) can be used as a supplement for hMSCs culture, since UCB is rich in soluble growth factors and due to worldwide increased number of cryopreserved UCB units in public and private banks, without the disadvantages listed for FBS. On the other hand, the culture media enriched in growth factors produced by these hMSCs in expansion (Conditioned medium--CM) can be an alternative to hMSCs application. The CM of the hMSCs from the UC might be a better therapeutic option compared to cell transplantation, as it can benefit from the local tissue response to the secreted molecules without the difficulties and complications associated to the engraftment of the allo- or xeno-transplanted cells. These facts drove us to know the detailed composition of the hUCBP and CM, by 1H-NMR and Multiplexing LASER Bead Technology. hUCBP is an adequate alternative for the FBS and the CM and hUCBP are important sources of growth factors, which can be used in MSCs-based therapies. Some of the major proliferative, chemotactic and immunomodulatory soluble factors (TGF-β, G-CSF, GM-CSF, MCP-1, IL-6, IL-8) were detected in high concentrations in CM and even higher in hUCBP. The results from 1H-NMR spectroscopic analysis of CM endorsed a better understanding of hMSCs metabolism during in vitro culture, and the relative composition of several metabolites present in CM and hUCBP was obtained. The data reinforces the potential use of hUCBP and CM in tissue regeneration and focus the possible use of hUCBP as a substitute for the FBS used in hMSCs in vitro culture.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Culture Media, Conditioned*
  • Female
  • Fetal Blood / metabolism*
  • Humans
  • Infant, Newborn
  • Mesenchymal Stem Cells / cytology*
  • Metabolomics*
  • Pregnancy

Substances

  • Culture Media, Conditioned

Grants and funding

This research was supported by QREN I&DT Cluster in Development of Products for Regenerative Medicine and Cell Therapies - Projects Biomat & Cell QREN 2008/1372, co-financed by the European Community FEDER fund through ON2 - O Novo Norte - North Portugal Regional Operational Program 2007–2013, by QREN n ° 38853/2013 - " Soluções avançadas de regeneração óssea com base em hidrogéis de dextrin - DEXGELERATION", by project "Hybrid Nanostructured Hydrogels: Bone regeneration using Multifunctional injectable Hydrogels - Rebone" - ENMED/0002/2010, and by the program COMPETE - Programa Operacional Factores de Competitividade, Project Pest-OE/AGR/UI0211/2011, and from FCT project PTDC/CVT/103081/2008. The co-author A Almeida is supported by a Post-Doc grant from FCT under the reference SFRH/BPD/79539/2011. The Bruker Avance III HD 600 MHz NMR spectrometer was purchased under the framework of QREN, through project NORTE-07-0162-FEDER-000048, and is part of the Portuguese National NMR Network. The authors would like to state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.